All In Biotech

Drug Trial Radar · NCT07187973

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

A Phase 1b Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DISC-3405 in Participants With Sickle Cell Disease

Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

24

Planned (sponsor's estimate)

Start

Jan 6, 2026

Primary completion

Jun 2027

Study completion Oct 2027

Sponsor

Lead sponsor
Disc Medicine, IncIndustry
Sponsor type
Industry
First posted
Sep 23, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an open-label, multicenter, within-participant dose-escalation study examining up to 3 dose levels of DISC-3405 and will assess the safety, tolerability, PK, and PD of DISC 3405 in participants with sickle cell disease.

Conditions

  • Sickle Cell Disease

Interventions

  • DISC-3405Drug

    DISC-3405 is administered subcutaneously.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and tolerability of DISC-3405 administration in participants with SCDTime frame: Up to 36 weeks

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama · Recruiting

  • University of California San Francisco (UCSF) Medical Center

    San Francisco, California · Recruiting

  • Emory University

    Atlanta, Georgia · Recruiting

  • Augusta University

    Augusta, Georgia · Recruiting

  • University of Illinois Hospital and Health Sciences System

    Chicago, Illinois · Recruiting

  • Innovative Hematology - Indiana Hemophilia & Thrombosis Center

    Indianapolis, Indiana · Recruiting

  • Mount Sinai Hospital

    New York, New York · Recruiting

  • Duke University Medical Center

    Durham, North Carolina · Recruiting

  • Brody School of Medicine at East Carolina University

    Greenville, North Carolina · Recruiting

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio · Recruiting

  • University of Pittsburgh Medical Center (UPMC)

    Pittsburgh, Pennsylvania · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.